US 8663635
N-cadherin: target for cancer diagnosis and therapy
granted A61KA61K2039/505A61P
Quick answer
US patent 8663635 (N-cadherin: target for cancer diagnosis and therapy) held by The Regents of the University of California expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61P, A61P13/08, A61P35/00